Drug Pricing

Securing Affordable Treatments for All Americans

Anticompetitive practices within the pharmaceutical industry, coupled with outdated patent laws that inhibit more affordable biosimilars and generics, have resulted in skyrocketing drug costs for all Americans – but especially seniors and those with chronic conditions. ACHP advocates for sensible policies such as price transparency to reign in sky-high costs so that patients can afford the medications they need.

Facts & Figures

icon

ACHP plans partner with

Civica Rx

to address drug shortages and high prices.

image-card

FACT SHEET — Curbing High Drug Costs

Download
Resource Library Search

Keeping the Consumer First: It’s Time to Address Misleading Medicare Advantage Marketing

Misleading marketing is tricking seniors into choosing subpar Medicare Advantage coverage–it's time for CMS to take action.

11/29/2022

ACHP Letter to CMS on Medicare Advantage Marketing Practices

The Alliance of Community Health Plans (ACHP) has sent a letter to the Centers for Medicare and Medicaid Services (CMS) addressing misleading and deceptive marketing practices occurring in the Medicare …

11/28/2022

Medicare Advantage: The Choice of America’s Seniors

By offering lower costs, more benefits and better outcomes, Medicare Advantage is increasingly becoming the Choice of America's Seniors.

Medicaid Redetermination: Preparing for the End of the Public Health Emergency

ACHP and its member companies are committed to ensuring that Medicaid enrollees have access to affordable health coverage options once states begin Medicaid eligibility redeterminations.

ACHP Urges Action on Virtual Care, Medicaid in 2022 Lame Duck Session

ACHP has sent a letter to Congressional Leadership urging lawmakers to act on important health care policies during the lame duck session. By acting swiftly on critical issues including virtual …

11/17/2022

Loading…
Making Health Care Better

ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.

icon-arrow
client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo
icon-arrow

Stay Connected